Shehzad A. Saeed

Pediatric Gastroenterology

1 Childrens Plz
Dayton, OH 45404

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

The ImproveCareNow Registry: Prediction of remission rates in paediatric Crohn's disease.

The ImproveCareNow Registry: Prediction of remission rates in paediatric Crohn's disease.

Journal: Journal of pediatric gastroenterology and nutrition

Published: March 30, 2026

The ImproveCareNow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis.

The ImproveCareNow registry: Prediction of 2-year nonremission in pediatric ulcerative colitis.

Journal: Journal of pediatric gastroenterology and nutrition

Published: September 08, 2025

Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.

Evaluation of pharmacokinetic metrics and pharmacodynamic biomarkers associated with endoscopic healing in pediatric Crohn's disease patients treated with anti-tumor necrosis factor biologics.

Journal: Crohn's & colitis 360

Published: August 05, 2025

The Pediatric Experience Collaborative: Paving the Way in Pediatric Experience.

The Pediatric Experience Collaborative: Paving the Way in Pediatric Experience.

Journal: Journal of patient experience

Published: July 09, 2025

Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease: A Nationwide Survey of Anti-TNF Therapy Practices, Attitudes, and Barriers.

Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease: A Nationwide Survey of Anti-TNF Therapy Practices, Attitudes, and Barriers.

Journal: Crohn's & colitis 360

Published: April 25, 2025

Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System.

Infliximab Biosimilar Utilization in a Large Pediatric Learning Health System.

Journal: Children (Basel, Switzerland)

Published: April 09, 2025

Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study.

Effectiveness and safety of ustekinumab in pediatric Crohn's disease: Results of the REALITI study.

Journal: Journal of pediatric gastroenterology and nutrition

Published: February 14, 2025

Standardized biopsy protocols improve adherence to eosinophilic esophagitis and celiac disease endoscopic biopsy guidelines.

Standardized biopsy protocols improve adherence to eosinophilic esophagitis and celiac disease endoscopic biopsy guidelines.

Journal: JPGN reports

Published: July 18, 2024

Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.

Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's Disease.

Journal: Inflammatory bowel diseases

Published: June 12, 2024

HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's Disease.

Journal: The American journal of gastroenterology

Published: May 12, 2024

National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease.

National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease.

Journal: JPGN reports

Published: May 02, 2024

Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease.

Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: February 21, 2024

Showing 1-12 of 81

Last Updated: 09/26/2026